Interacting Drugs |
Bacitracin, neomycin, and polymyxin B vs SORAfenib |
Security Level |
|
Mechanism |
SORAfenib: Neomycin may decrease the serum concentration of SORAfenib. |
Management |
Monitor therapy |
Bacitracin, neomycin, and polymyxin B vs SORAfenib
Post Review about Bacitracin, neomycin, and polymyxin B vs SORAfenib Click here to cancel reply.
Other Interactions of Bacitracin, neomycin, and polymyxin B
Other Interactions of SORAfenib
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.